K. Thai, M. Gravel / Tetrahedron: Asymmetry 21 (2010) 751–755
755
1739, 1691, 1478, 1460, 1438, 1390, 1362, 1323, 1288, 1253, 1225,
4.3.8. (S)-1-[4,4-Dicyano-3-(furan-2-yl)butanoyl]pyrrolidin-2-
one (3h)
1193, 1039, 1024, 913, 761 cmꢀ1; 1H NMR (500 MHz, CDCl3) d 7.42
(dd, J = 7.5, 1.5 Hz, 1H), 7.36 (dd, J = 7.5, 1.5 Hz, 1H), 7.24–7.16 (m,
2H), 4.51 (d, J = 7.0 Hz, 1H), 4.48–4.44 (m, 1H), 3.71–3.65 (m, 2H),
3.60–3.47 (m, 2H), 2.54–2.50 (m, 2H), 2.00–1.92 (m, 2H); 13C NMR
(125 MHz, CDCl3) d 175.9, 170.4, 134.3, 134.2, 130.6, 130.3,
128.5128.0, 111.8, 111.4, 45.6, 38.5, 37.4, 33.5, 27.5, 17.4; HRMS
(EI+) m/z calcd for C16H14ClN3O2 [M]+: 315.0774, found:
315.0789. HPLC [CHIRALPAKÒ AS-H, EtOH/hexanes = 15/75,
0.1 mL/min, k = 254 nm, retention times: (major) 26.5 min, (minor)
30.7 min].
Colorless oil. 1H NMR (500 MHz, CDCl3) d 7.47–7.42 (m, 1H),
6.47–6.36 (m, 2H), 4.57 (d, J = 5.8 Hz, 1H), 4.02 (dt, J = 5.7 Hz,
1H), 3.81 (t, J = 7.2 Hz, 2H), 3.62 (d, J = 18.9, 5.7 Hz, 1H), 3.52 (d,
J = 18.9, 8.2 Hz, 1H), 2.68–2.58 (m, 2H), 2.14–2.02 (m, 2H). HPLC
[CHIRALPAKÒ IC, iPrOH/hexanes = 15/75, 0.1 mL/min, k = 254 nm,
retention times: (minor) 40.8 min, (major) 48.7 min].
4.3.9. (S)-1-[4,4-Dicyano-3-methylbutanoyl]pyrrolidin-2-one
(3i)
Colorless oil. 1H NMR (500 MHz, CDCl3) d 4.41 (d, J = 4.9 Hz, 1H),
3.80 (t, J = 7.2 Hz, 2H), 3.18 (dd, J = 18.6, 4.9 Hz, 1H), 3.08 (dd,
J = 18.6, 8.7 Hz, 1H), 2.77–2.67 (m, 1H), 2.62 (t, J = 8.1 Hz, 2H),
2.14–2.04 (m, 2H), 1.36 (d, J = 6.7 Hz, 3H). HPLC [CHIRALPAKÒ
AS-H, EtOH/hexanes = 20/80, 0.1 mL/min, k = 254 nm, retention
times: 13.9 min, 15.5 min].
4.3.4. (S)-1-[3-(3-Chlorophenyl)-4,4-dicyanobutanoyl]
pyrrolidin-2-one (3d)
White precipitate; mp 123–125 °C; FTIR
1598, 1574, 1479, 1460, 1435, 1390, 1362, 1322, 1250, 1192, 1082
cmꢀ1 1H NMR (500 MHz, CDCl3) d 7.38–7.35 (m, 3H), 7.32–7.30
mmax 1738, 1687, 1682,
;
(m, 1H), 4.56 (d, J = 6.3 Hz, 1H), 3.84–3.75 (m, 3H), 3.63–3.53 (m,
2H), 2.62 (dddd, J = 8.4, 8.4, 4.2, 4.2 Hz, 2H), 2.12–2.02 (m, 2H);
13C NMR (125 MHz, CDCl3) d 175.9, 170.6, 138.5, 135.3, 130.8,
129.6, 128.5, 126.5, 111.9, 111.5, 45.6, 41.5, 39.0, 33.5, 28.8, 17.4;
HRMS (EI+) m/z calcd for C16H14ClN3O2 [M]+: 315.0775, found:
315.0775. HPLC [CHIRALPAKÒ AS-H, EtOH/hexanes = 15/85,
0.1 mL/min, k = 254 nm, retention times: (major) 26.4 min, (minor)
30.6 min].
Acknowledgments
We thank the Natural Sciences and Engineering Research Coun-
cil of Canada (NSERC), the Canada Foundation for innovation (CFI),
and the University of Saskatchewan for financial support.
References
1. For reviews, see: (a) Best, M. D.; Tobey, S. L.; Anslyn, E. V. Coord. Chem. Rev.
2003, 240, 3–15; (b) Schug, K. A.; Lindner, W. Chem. Rev. 2005, 105, 67–113; (c)
Blondeau, P.; Segura, M.; Pérez-Fernández, R.; de Mendoza, J. Chem. Soc. Rev.
2007, 36, 198–210; (d) Berlinck, R. G. S.; Burtoloso, A. C. B.; Kossuga, M. H. Nat.
Prod. Rep. 2008, 25, 919–954.
2. For reviews on guanidines in organic synthesis, see: (a) Ishikawa, T.; Isobe, T.
Chem. Eur. J. 2002, 8, 552–557; (b) Ishikawa, T.; Kumamoto, T. Synthesis 2006,
737–752.
3. For a review on the use of chiral guanidines as organocatalysts, see: (a) Leow,
D.; Tan, C.-H. Chem. Asian J. 2009, 4, 488–507. For selected examples, see:; (b)
Echavarren, A.; Galán, A.; Lehn, J.-M.; de Mendoza, J. J. Am. Chem. Soc. 1989, 111,
4994–4995; (c) Kurzmeier, H.; Schmidtchen, F. P. J. Org. Chem. 1990, 55, 3749–
3755; (d) Iyer, M. S.; Gigstad, K. M. J. Am. Chem Soc. 1996, 118, 4910–4911; (e)
Corey, E. J.; Grogan, J. M. Org. Lett. 1999, 1, 157–160; (f) Terada, M.; Ube, H.;
Yaguchi, Y. J. Am. Chem. Soc. 2006, 128, 1454–1455; (g) Sohtome, Y.; Hashimoto,
Y.; Nagasawa, K. Eur. J. Org. Chem. 2006, 2894–2897; (h) Uyeda, C.; Jacobsen, E.
N. J. Am. Chem. Soc. 2008, 130, 9228–9229; (i) Yu, Z.; Liu, X.; Zhou, L.; Lin, L.;
Feng, X. Angew. Chem., Int. Ed. 2009, 48, 5195–5198; (j) Jiang, Z.; Yang, Y.; Pan,
Y.; Zhao, Y.; Liu, H.; Tan, C.-H. Chem. Eur. J. 2009, 15, 4925–4930; (k) Lovick, H.
M.; Michael, F. E. Tetrahedron Lett. 2009, 50, 1016–1019; (l) Fu, X.; Loh, W.-T.;
Zhang, Y.; Chen, T.; Ma, T.; Liu, H.; Wang, J.; Tan, C.-H. Angew. Chem., Int. Ed.
2009, 48, 7387–7390.
4.3.5. (S)-1-[3-(4-Fluorophenyl)-4,4-dicyanobutanoyl]
pyrrolidin-2-one (3e)
Colorless oil. 1H NMR (500 MHz, CDCl3) d 7.40 (dd, J = 8.4,
5.0 Hz, 2H), 7.11 (t, J = 8.6 Hz, 2H), 4.57 (d, J = 5.5 Hz, 1H), 3.90–
3.72 (m, 3H), 3.64–3.51 (m, 2H), 2.69–2.54 (m, 2H), 2.15–1.99
(m, 2H). HPLC [CHIRALPAKÒ IB, EtOH/hexanes = 30/70, 0.1 mL/
min, k = 254 nm, retention times: (minor) 16.1 min, (major)
17.5 min].
4.3.6. (S)-2-(3-Oxo-3-(2-oxopyrrolidin-1-yl)-1-p-tolylpropy)
malononitrile (3f)
Colorless oil. FTIR mmax 1740, 1686, 1419, 1388, 1250, 1224, 730,
637; 1H NMR (500 MHz, CDCl3) d 7.29 (d, J = 7.8 Hz, 2H), 7.22 (d,
J = 8.2 Hz, 2H), 4.54 (d, J = 5.2 Hz, 1H), 3.82–3.78 (m, 3H), 3.59–
3.58 (m, 2H), 2.64–2.60 (m, 2H), 2.36 (s, 3H), 2.11–2.05 (m, 2H);
13C NMR (125 MHz, CDCl3) d 175.8, 171.1, 139.2, 133.5, 130.1,
128.1, 112.2, 111.8, 45.6. 41.5, 39.2, 33.6, 29.2, 21.4, 17.4; HRMS
(EI+) m/z calcd for C17H17N3O2 [M]+: 295.1321, found: 295.1322.
HPLC [CHIRALPAKÒ IB, iPrOH/hexanes = 10/90, 0.1 mL/min,
k = 254 nm, retention times: (minor) 43.3 min, (major) 46.4 min].
4. Recently, Nájera and co-workers reported the use of chiral 2-
aminobenzimidazoles as organocatalysts for the conjugate addition of 1,3-
dicarbonyl compounds to nitroalkenes in high yields and enantioselectivity:
Almaßsi, D.; Alonso, D. A.; Gómez-Bengoa, E.; Nájera, C. J. Org. Chem. 2009, 74,
6163–6168.
5. For reviews, see: (a) Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2006, 45,
1520–1543; (b) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713–5743;
(c) Akiyama, T. Chem. Rev. 2007, 107, 5744–5758.
6. For reviews, see: (a) Takemoto, Y. Org. Biomol. Chem. 2005, 3, 4299–4306; (b)
Connon, S. J. Chem. Eur. J. 2006, 12, 5418–5427; (c) Zhang, Z. G.; Schreiner, P. R.
Chem. Soc. Rev. 2009, 38, 1187–1198; (d) Connon, S. J. Synlett 2009, 354–376.
7. (a) Hoashi, Y.; Okino, T.; Takemoto, Y. Angew. Chem., Int. Ed. 2005, 44, 4032–
4035; (b) Okino, T.; Hashi, Y.; Furukawa, T.; Xu, X.; Takemoto, Y. J. Am. Chem.
Soc. 2005, 127, 119–126; (c) Inokuma, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem.
Soc. 2006, 128, 9413–9419.
4.3.7. (S)-Methyl 4-(1,1-dicyano-4-oxo-4-(2-oxopyrrolidin-1-
yl)butan-2-yl)benzoate (3g)
Compound 3g was isolated by column chromatography (1:1
hexanes/EtOAc, Rf = 0.26) to yield a colorless oil (53% yield). FTIR
mmax 1724, 1688, 1613, 1437, 1421, 1390, 1363, 1286, 1193,
1113, 1020, 914, 860, 772, 599 cmꢀ1 1H NMR (500 MHz, CDCl3)
;
d
8.10 (d, J = 8.2 Hz, 2H), 7.50 (d, J = 8.4 Hz, 2H), 4.59 (d,
8. Herrera, R. P.; Sgarzani, V.; Bernardi, L.; Ricci, A. Angew. Chem., Int. Ed. 2005, 44,
6576–6579.
9. Shi, Y.-L.; Shi, M. Adv. Synth. Catal. 2007, 349, 2129–2135.
10. Atwal, K. S.; Ahmed, S. Z.; O’Reilly, B. C. Tetrahedron Lett. 1989, 30, 7313–7316.
11. Thai, K.; Clement, C. W.; Gravel, M. Tetrahedron Lett. 2009, 50, 6540–6542.
12. Zhang, J.; Shi, Y. Tetrahedron Lett. 2000, 41, 8075–8078.
13. Pescatori, L.; Arduini, A.; Pochini, A.; Ugozzoli, F.; Secchi, A. Eur. J. Org. Chem.
2008, 109–120.
J = 5.7 Hz, 1H), 3.91–3.88 (m, 4H), 3.80–3.75 (m, 2H), 3.62–3.60
(m, 2H), 2.63–2.59 (m, 2H), 2.08–2.04 (m, 2H); 13C NMR
(125 MHz, CDCl3) d 178.0, 170.6, 166.6, 141.3, 131.1, 130.7,
128.4, 111.8, 111.5, 52.5, 45.6, 41.6, 38.9, 33.5, 28.7, 17.4; HRMS
(EI+) m/z calcd for C18H17N3O4 [M]+: 339.1219, found: 339.1217.
HPLC [CHIRALPAKÒ AS-H, EtOH/hexanes = 40/60, 0.1 mL/min,
k = 254 nm, retention times: (minor) 18.0 min, (major) 20.8 min].